195 related articles for article (PubMed ID: 11100822)
1. Asymptomatic brain metastases (BM) in small cell lung cancer (SCLC): MR-imaging is useful at initial diagnosis.
Hochstenbag MM; Twijnstra A; Wilmink JT; Wouters EF; ten Velde GP
J Neurooncol; 2000 Jul; 48(3):243-8. PubMed ID: 11100822
[TBL] [Abstract][Full Text] [Related]
2. Response of asymptomatic brain metastases from small-cell lung cancer to systemic first-line chemotherapy.
Seute T; Leffers P; Wilmink JT; ten Velde GP; Twijnstra A
J Clin Oncol; 2006 May; 24(13):2079-83. PubMed ID: 16648509
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic cranial irradiation in limited-stage small-cell lung cancer: a retrospective analysis.
Alshehadat S; Sahmoun AE
Clin Adv Hematol Oncol; 2004 Jun; 2(6):397-400. PubMed ID: 16163213
[TBL] [Abstract][Full Text] [Related]
4. Detection of brain metastases from small cell lung cancer: consequences of changing imaging techniques (CT versus MRI).
Seute T; Leffers P; ten Velde GP; Twijnstra A
Cancer; 2008 Apr; 112(8):1827-34. PubMed ID: 18311784
[TBL] [Abstract][Full Text] [Related]
5. Patients with limited-stage small-cell lung cancer treated with concurrent twice-daily chest radiotherapy and etoposide/cisplatin followed by cyclophosphamide, doxorubicin, and vincristine.
Johnson BE; Bridges JD; Sobczeck M; Gray J; Linnoila RI; Gazdar AF; Hankins L; Steinberg SM; Edison M; Frame JN; Pass H; Nesbitt J; Holden D; Mulshine JL; Glatstein E; Ihde DC
J Clin Oncol; 1996 Mar; 14(3):806-13. PubMed ID: 8622028
[TBL] [Abstract][Full Text] [Related]
6. Pilot study of cyclophosphamide-doxorubicin-vincristine-cisplatin-etoposide hybrid chemotherapy in small cell lung cancer.
Ohnoshi T; Hiraki S; Ueoka H; Kiura K; Kamei H; Horiguchi T; Kodani T; Maeda T; Tabata M; Shibayama T
Cancer; 1993 Sep; 72(5):1597-601. PubMed ID: 8394202
[TBL] [Abstract][Full Text] [Related]
7. Outcome and prognostic factors in single brain metastases from small-cell lung cancer.
Bernhardt D; Adeberg S; Bozorgmehr F; Opfermann N; Hörner-Rieber J; König L; Kappes J; Thomas M; Unterberg A; Herth F; Heußel CP; Warth A; Debus J; Steins M; Rieken S
Strahlenther Onkol; 2018 Feb; 194(2):98-106. PubMed ID: 29085978
[TBL] [Abstract][Full Text] [Related]
8. Response of brain metastases from lung cancer to systemic chemotherapy with carboplatin and etoposide.
Malacarne P; Santini A; Maestri A
Oncology; 1996; 53(3):210-3. PubMed ID: 8643223
[TBL] [Abstract][Full Text] [Related]
9. Concurrent cisplatin, prolonged oral etoposide, and vincristine plus chest and brain irradiation for limited small cell lung cancer: a phase II study of the Southwest Oncology Group (SWOG-9229).
Thomas CR; Giroux DJ; Stelzer KJ; Craig JB; Laufman LR; Taylor SA; Goodwin JW; Crowley JJ; Livingston RB
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1039-47. PubMed ID: 9539558
[TBL] [Abstract][Full Text] [Related]
10. Alternating chemotherapy with cyclophosphamide, doxorubicin, vincristine and cisplatin, etoposide followed by prophylactic cranial and thoracic irradiation for small cell lung cancer (SCLC): long-term results.
Ardizzoni A; Fusco V; Pennucci C; Baldini E; Orsatti M; Vitale V; Bonavia M; Baracco F; Mereu C; Rosso R
Anticancer Res; 1991; 11(2):681-4. PubMed ID: 1648333
[TBL] [Abstract][Full Text] [Related]
11. Primary chemotherapy of brain metastasis in small-cell lung cancer.
Lee JS; Murphy WK; Glisson BS; Dhingra HM; Holoye PY; Hong WK
J Clin Oncol; 1989 Jul; 7(7):916-22. PubMed ID: 2544685
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin plus etoposide with and without ifosfamide in extensive small-cell lung cancer: a Hoosier Oncology Group study.
Loehrer PJ; Ansari R; Gonin R; Monaco F; Fisher W; Sandler A; Einhorn LH
J Clin Oncol; 1995 Oct; 13(10):2594-9. PubMed ID: 7595712
[TBL] [Abstract][Full Text] [Related]
13. [Systemic chemotherapy for brain metastasis from small cell lung cancer].
Tanaka H; Takifuji N; Masuda N; Takada M; Kudo S; Nakagawa K; Matsui K; Ito K; Kusunoki Y; Fukuoka M
Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Apr; 31(4):492-7. PubMed ID: 8390590
[TBL] [Abstract][Full Text] [Related]
14. The response of cerebral metastases in small cell lung cancer to systemic chemotherapy.
Twelves CJ; Souhami RL; Harper PG; Ash CM; Spiro SG; Earl HM; Tobias JS; Quinn H; Geddes DM
Br J Cancer; 1990 Jan; 61(1):147-50. PubMed ID: 2153393
[TBL] [Abstract][Full Text] [Related]
15. Surgery after initial chemotherapy for localized small-cell carcinoma of the lung.
Williams CJ; McMillan I; Lea R; Mead G; Thompson J; Sweetenham J; Herbert A; Jefferys M; Buchanan R; Whitehouse JM
J Clin Oncol; 1987 Oct; 5(10):1579-88. PubMed ID: 2821198
[TBL] [Abstract][Full Text] [Related]
16. Survival of patients with extensive small-cell lung cancer who have only brain metastases at initial diagnosis.
Kochhar R; Frytak S; Shaw EG
Am J Clin Oncol; 1997 Apr; 20(2):125-7. PubMed ID: 9124183
[TBL] [Abstract][Full Text] [Related]
17. Current standards of care in small-cell and non-small-cell lung cancer.
Schiller JH
Oncology; 2001; 61 Suppl 1():3-13. PubMed ID: 11598409
[TBL] [Abstract][Full Text] [Related]
18. Prophylactic cranial irradiation in complete responders with small-cell lung cancer: analysis of the Mayo Clinic and North Central Cancer Treatment Group data bases.
Shaw EG; Su JQ; Eagan RT; Jett JR; Maksymiuk AW; Deigert FA
J Clin Oncol; 1994 Nov; 12(11):2327-32. PubMed ID: 7964948
[TBL] [Abstract][Full Text] [Related]
19. MRI in detection of brain metastases at initial staging of small-cell lung cancer.
van de Pol M; van Oosterhout AG; Wilmink JT; ten Velde GP; Twijnstra A
Neuroradiology; 1996 Apr; 38(3):207-10. PubMed ID: 8741187
[TBL] [Abstract][Full Text] [Related]
20. Resectability of small-cell lung cancer following induction chemotherapy in patients with limited disease (stage II-IIIb).
Zatopek NK; Holoye PY; Ellerbroek NA; Hong WK; Roth JA; Ryan MB; Komaki R; Pang AC; Glisson BS
Am J Clin Oncol; 1991 Oct; 14(5):427-32. PubMed ID: 1659177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
